Toggle light / dark theme

Researchers at the University of Minnesota have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI) cancers. The results, recently published in The Lancet Oncology, show encouraging signs of the safety and potential effectiveness of the treatment.

“Despite many advances in understanding the genomic drivers and other factors causing cancer, with few exceptions, stage IV remains a largely incurable disease,” said Emil Lou, MD, Ph.D., a gastrointestinal oncologist with the University of Minnesota Medical School, Masonic Cancer Center and M Health Fairview, and clinical principal investigator for the trial. “This trial brings a new approach from our research labs into the clinic and shows potential for improving outcomes in patients with late-stage disease.”

In the study, researchers used CRISPR/Cas9 gene-editing to modify a type of immune cell called tumor-infiltrating lymphocytes (TILs). By deactivating a gene called CISH, the researchers found that modified TILs were better able to recognize and attack .

1 Comment so far

  1. What you published made a lot of sense. But, what about this? suppose you wrote a catchier title? I ain’t suggesting your content is not solid., however what if you added a headline that grabbed people’s attention? I mean %BLOG_TITLE% is kinda vanilla. You ought to peek at Yahoo’s front page and note how they write news headlines to grab people interested. You might add a related video or a pic or two to grab readers interested about what you’ve written. In my opinion, it could bring your website a little livelier.
    https://reklamist.com.ua/yak-stekla-na-far-mozhut-pidvyshchyty-vydymist-pid.html

Leave a Reply to Lhaneped Cancel reply

If you are already a member, you can use this form to update your payment info.

Lifeboat Foundation respects your privacy! Your email address will not be published.